Target intelligence / Profile preview

Biogenesis of lysosomal organelles complex 1 subunit 6 (pallidin) (BLOC1S6)

Target
BLOC1S6
Molecular classification
Other (component of protein complex), Structural subunit (BLOC-1 complex)
01

Overview

Biogenesis of lysosomal organelles complex 1 subunit 6 (BLOC1S6, also known as pallidin or PLDN) is an integral structural subunit of the BLOC-1 complex, which is required for the normal biogenesis and function of lysosome-related organelles such as melanosomes, platelet dense granules, and acrosomes[1][2]. The protein regulates intracellular vesicular trafficking, particularly the sorting and delivery of membrane protein cargos to specialized organelles. BLOC1S6 interacts with other BLOC-1 subunits (including dysbindin, muted, and snapin) and with SNARE proteins such as Syntaxin 13 to mediate vesicle docking and fusion[1][2]. Mutations or dysregulation of BLOC1S6 cause Hermansky-Pudlak syndrome type 9 and are implicated in the pathology of granule formation defects and pigmentation disorders[1][2][6]. It is not a receptor, enzyme, or transporter, but rather a scaffolding protein involved in organizing vesicle transport machinery. Currently, there are no approved drugs targeting BLOC1S6 directly, but its involvement in key cellular processes means defects have significant consequences for cellular function[1][2][6].

Other names
PallidinPLDNHPS9PABLOS6BLOC-1 subunit pallidinPallid protein homologBLOC-1 subunit 6Syntaxin 13 binding protein 1 (Stx13bp1)
02

Mechanism of action

Not applicable. There are no drugs targeting BLOC1S6, so mechanisms of action for drug-target interaction are not defined.

03

Biological functions

Intracellular vesicle traffickingCargo sorting to lysosome-related organelles (e.g., melanosomes, platelet dense granules, acrosomes)Endosome to melanosome transportProtein homodimerizationActin filament bindingVesicle docking and fusionStabilization of BLOC-1 complex and its interaction with SNARE proteins
04

Disease associations

Hermansky-Pudlak syndrome type 9Platelet dense granule deficiency (e.g., in RUNX1 haplodeficiency)Pigmentation disorders (melanosome dysfunction)
05

Safety considerations

Not applicable
06

Interacting drugs

None known
07

Biomarkers

Mutations in BLOC1S6 may serve as diagnostic biomarkers for Hermansky-Pudlak syndrome 9Downregulation/deficiency in PLDN (pallidin) expression may help stratify patients with platelet dense granule defects (RUNX1 haplodeficiency, HPS)

Beyond the preview

Go deeper on Biogenesis of lysosomal organelles complex 1 subunit 6 (pallidin) (BLOC1S6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogenesis of lysosomal organelles complex 1 subunit 6 (pallidin) (BLOC1S6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call